Mortality risk factors for bloodstream infections caused by extended-spectrum beta-lactamase-producing microorganisms;Factores de riesgo de mortalidad en pacientes con bacteriemia por cepas productoras de betalactamasas de espectro extendido

Revista Clinica Espanola

Volumn 211, Issue 3, 2011, Pages 119-126

  Ferrandez O ^a   Grau, S ^a   Saballs, P ^a   Luque, S ^a   Terradas, R ^a   Salas, E ^a  

^a HOSPITAL DEL MAR   (Spain)

Author keywords

Bacteremia; Extended spectrum beta lactamases; Mortality risk factor

Indexed keywords

ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BLOODSTREAM INFECTION; DISEASE SEVERITY; ESCHERICHIA COLI; GROUPS BY AGE; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MORTALITY; URINARY TRACT INFECTION;

AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; INTENSIVE CARE UNITS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; PATIENT ADMISSION; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 79953118520     PISSN: 00142565     EISSN: 15781860     Source Type: Journal    
DOI: 10.1016/j.rce.2010.05.027     Document Type: Article

References (23)

1. M.J. Schwaber, and Y. Carmeli Mortality and delay in effective therapy associated with extended-spectrum β-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis J Antimicrob Chemother. 60 2007 913 920 (Pubitemid 47617735)
2. C.I. Kang, S.H. Kim, W.B. Park, K.D. Lee, H.B. Kim, and E.C. Kim Bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy Antimicrob Agents Chemother. 48 2004 4574 4581
3. M. Tumbarello, M. Sanguinetti, E. Montuori, E.M. Trecarichi, B. Posteraro, and B. Fiori Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment Antimicrob Agents Chemother. 51 2007 1987 1994 (Pubitemid 46903084)
4. G. Metan, P. Zarakolu, B. akir, G. Hascelik, and O. Uzun Clinical outcomes and therapeutic options of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli Int J Antimicrob Agents. 26 2005 254 257 (Pubitemid 41219613)
5. D.J. Anderson, J.J. Engemann, L.J. Harrell, Y. Carmeli, L.B. Reller, and K.S. Kaye Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae Antimicrob Agents Chemother. 50 2006 1715 1720
6. J.S. Garner, W.R. Jarvis, T.G. Emori, T.C. Horan, and J.M. Hughes CDC definitions for nosocomial infections Am J Infect Control. 16 1988 128 140
7. N.D. Friedman, K.S. Kaye, J.E. Stout, S.A. McGarry, S.L. Trivette, and J.P. Briggs Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections Ann Intern Med. 137 2002 791 797 (Pubitemid 35334450)
8. J. Le Gall, S. Lemeshow, and F. Saulnier A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study JAMA. 270 1993 2957 2963 (Pubitemid 24000804)
9. P.R. Hutson Hematology: red and White blood cell tests M. Lee, Basic skills in interpreting laboratory data. 2004 American Society of Health-System Pharmacists Bethesda 441 467
10. I. Siempos, E. Ioannidou, and M. Falagas The difference between adequate and appropriate antimicrobial treatment Clin Infect Dis. 46 2008 642 644 (Pubitemid 351263511)
11. Performance standards for antimicrobial susceptibility testing: 20th informational supplement. Wayne: CLSI; 2010. p. M100-20.
12. C.H. Lee, L.H. Su, Y.F. Tang, and J.W. Liu Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef:a retrospective study and laboratory analysis of the isolates J Antimicrob Chemother. 58 2006 1074 1077
13. H.S. Cheong, C.I. Kang, K.T. Kwon, S.T. Heo, Y.M. Wi, and E.S. Kim Clinical significance of healthcare-associated infections in community-onset Escherichia coli bacteraemia J Antimicrob Chemother. 60 2007 1355 1360 (Pubitemid 350168333)
14. C. Peña, C. Gudiol, L. Calatayud, F. Tubau, M.A. Dominguez, and M. Pujol Infections due to Escherichia coli producing extended-spectrum β-lactamase among hopitalised patients:factors influencing mortality J Hosp Infect. 68 2008 116 122
15. E.P. Hyle, A.D. Lipworth, T.E. Zaoutis, I. Nachamkin, W.B. Bilker, and E. Lautenbach Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae. Variability by site of infection Arch Intern Med. 165 2005 1375 1380 (Pubitemid 40973420)
16. C.I. Kang, H.S. Cheong, D.R. Chung, K.R. Peck, J.H. Song, and M.D. Oh Clinical features and outcome of community-onset bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli Eur J Clin Microbiol Infect Dis. 27 2008 85 88 (Pubitemid 350197875)
17. C.I. Kang, S.H. Kim, D.M. Kim, W.B. Park, K.D. Lee, and H.B. Kim Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae Infect Control Hosp Epidemiol. 25 2004 860 867 (Pubitemid 40036764)
18. M. Tumbarello, T. Spanu, M. Sanguinetti, R. Citton, E. Montuori, and F. Leone Bloodstream infections caused by extended-spectrum β-lactamase- producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome Antimicrob Agents Chemother. 50 2006 498 504 (Pubitemid 43190958)
19. J.C. McGregor, S.E. Rich, A.D. Harris, E.N. Perencevich, R. Osih, and T.P. Lodise A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients Clin Infect Dis. 45 2007 329 337 (Pubitemid 47101029)
20. E. Elliott, A.J. Brink, J. Van Greune, Z. Els, N. Woodford, and J. Turton In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum beta-lactamase Clin Infect Dis. 42 2006 e95 e98
21. C. Lagatolla, E.A. Tonin, C. Monti-Bragadin, L. Dolzani, F. Gombac, and C. Bearzi Endemic carbapenem-resistant Pseudomonas aeruginosa with acquired metallo- β-lactamase determinants in european hospital Emerg Infect Dis. 10 2004 535 538 (Pubitemid 38314491)
22. J. Pope, J. Adams, Y. Doi, D. Szabo, and D.L. Paterson KPC type β-lactamase, rural Pennsylvania Emerg Infect Dis. 12 2006 1613 1614 (Pubitemid 44570918)
23. T. Hong, E.S. Moland, B. Abdalhamid, N.D. Hanson, J. Wang, and C. Sloan Escherichia coli: development of carbapenem resistance during therapy Clin Infect Dis. 40 2005 e84 e86